Results 211 to 220 of about 12,289 (268)

Placenta Accreta Spectrum Without Placenta Previa

Obstetrics & Gynecology, 2020
OBJECTIVE: To evaluate placenta accreta spectrum with and without placenta previa with regard to risk factors, antepartum diagnosis, and maternal morbidity. METHODS: We conducted a retrospective cohort study of pathology-confirmed placenta accreta spectrum deliveries with ...
Daniela A, Carusi, Karin A, Fox, Deirdre J, Lyell, Nicola C, Perlman, Soroush, Aalipour, Brett D, Einerson, Michael A, Belfort, Robert M, Silver, Alireza A, Shamshirsaz   +8 more
openaire   +2 more sources

Prenatal diagnosis of placenta accreta spectrum

Current Opinion in Obstetrics & Gynecology, 2022
Purpose of review Placenta accreta spectrum (PAS) is a major cause of severe maternal morbidity. Perinatal outcomes are significantly improved when PAS is diagnosed prenatally. However, a large proportion of cases of PAS remain undiagnosed until delivery.
Charlotte L, Conturie, Deirdre J, Lyell
openaire   +2 more sources

Anesthesia Considerations for Placenta Accreta Spectrum

American Journal of Perinatology, 2023
Anesthesiologists are critical members of the multidisciplinary team managing patients with suspected placenta accreta spectrum (PAS). Preoperatively, anesthesiologists provide predelivery consultation for patients with suspected PAS where anesthetic modality and invasive monitor placement is discussed.
Christine M, Warrick, Caitlin D, Sutton, Michaela M, Farber, Philip E, Hess, Alexander, Butwick, John C, Markley   +5 more
openaire   +2 more sources

Placenta Accreta Spectrum and Postpartum Hemorrhage

Clinical Obstetrics & Gynecology, 2023
Placenta accreta spectrum is a group of disorders involving abnormal trophoblastic invasion to the deep layers of endometrium and myometrium. Placenta accrete spectrum is one of the major causes of severe maternal morbidity, with increasing incidence in the past decade mainly secondary to an increase in cesarean deliveries. Severity varies depending on
Mahmoud, Abdelwahab, Michael, Cackovic
openaire   +2 more sources

A mouse model of placenta accreta spectrum

Placenta, 2020
Placenta Accreta Spectrum (PAS) disorder is one of the leading causes of maternal morbidity and mortality due to uncontrollable hemorrhage. The greatest risk factor for development of PAS is prior uterine surgery, frequently cesarean delivery. Despite considerable clinical knowledge, animal models of PAS are lacking.
Suzanne D, Burke, Zsuzsanna K, Zsengellér, S Ananth, Karumanchi, Scott A, Shainker   +3 more
openaire   +2 more sources

Timing of delivery for placenta accreta spectrum: the Pan-American Society for the Placenta Accreta Spectrum experience

American Journal of Obstetrics & Gynecology MFM, 2022
The Society for Maternal-Fetal Medicine recommends cesarean delivery with potential hysterectomy scheduled in the late preterm period between 34 0/7 and 35 6/7 weeks of gestation for prenatally suspected placenta accreta spectrum.We aimed to investigate clinical compliance with the recommended delivery timing window for placenta accreta spectrum and ...
Bahram, Salmanian, Brett D, Einerson, Daniela A, Carusi, Scott A, Shainker, Albaro J, Nieto-Calvache, Vineet K, Shrivastava, Akila, Subramaniam, Lisa C, Zuckerwise, Deirdre J, Lyell, Meena, Khandelwal, Garrett D, Fitzgerald, Kamran, Hessami, Karin A, Fox, Robert M, Silver, Alireza A, Shamshirsaz   +14 more
openaire   +2 more sources

Diagnostic accuracy of the placenta accreta index for placenta accreta spectrum: A prospective study

International Journal of Gynecology & Obstetrics, 2021
AbstractObjectiveTo evaluate the role of the placenta accreta index (PAI) score in predicting placenta accreta spectrum (PAS).MethodsIn this prospective study, the PAI was applied to 100 third‐trimester pregnant women with at least one previous cesarean delivery (CS) and anterior low‐lying placenta or placenta previa.
Hatem, Abu Hashim, Eman M, Shalaby, Mohammed H, Hussien, Mohamed, El Rakhawy   +3 more
openaire   +2 more sources

Are international guideline recommendations for the management of placenta accreta spectrum applicable in low‐ and middle‐income countries?

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
The aim of this study was to explore how obstetricians‐gynecologists in low‐ and middle‐income countries (LMICs) can apply current international clinical practice guidelines (CPGs) for the management of placenta accreta spectrum (PAS) in limited resource
Á. Nieto-Calvache, E. Jauniaux, Karin A. Fox, J. Maya, Vedran Stefanovic, Katharina Weizsäcker, H. V. van Beekhuizen, T. Adu-Bredu, S. Collins, Monica Siaulys, A. Hussein, Johannes J Duvekot, R. Aryananda, E. Pajkrt, M. Rijken   +14 more
semanticscholar   +1 more source

Risk factors for placenta accreta spectrum without prior cesarean section: A case–control study in China

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
To identify the risk factors for placenta accreta spectrum (PAS) disorders in women without prior cesarean section (CS).
Huanyu You, Yan Wang, Rui Han, Jinyu Gu, Lin Zeng, Yangyu Zhao   +5 more
semanticscholar   +1 more source

Updates on the management of placenta accreta spectrum

Minerva Ginecologica, 2019
Placenta accreta spectrum (PAS) disorders is a multifactorial process that encompasses a heterogeneous group of conditions characterized by an abnormal invasion of trophoblastic tissue through the myometrium and uterine serosa. PAS is associated with a high burden of adverse maternal outcomes including severe life-threatening hemorrhage, need for blood
Di Mascio, Daniele, Calì, Giuseppe, D'antonio, Francesco   +2 more
openaire   +2 more sources